CorMedix Inc.
Symbol: CRMD (NASDAQ)
Company Description:
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
- Today's Open: $11.778
- Today's High: $11.778
- Today's Low: $11.76
- Today's Volume: 770
- Yesterday Close: $11.65
- Yesterday High: $12.45
- Yesterday Low: $11.56
- Yesterday Volume: 3.27M
- Last Min Volume: 20
- Last Min High: $11.76
- Last Min Low: $11.76
- Last Min VWAP: $11.76
- Name: CorMedix Inc.
- Website: https://www.cormedix.com
- Listed Date: 2010-05-13
- Location: BERKELEY HEIGHTS, NJ
- Market Status: Active
- CIK Number: 0001410098
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $949.19M
- Round Lot: 100
- Outstanding Shares: 78.06M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-10-20 | 8-K | View |
2025-10-14 | PRER14A | View |
2025-10-07 | S-3ASR | View |
2025-10-07 | RW | View |
2025-10-06 | S-3ASR | View |
2025-10-06 | RW | View |
2025-09-30 | S-3 | View |
2025-09-30 | 8-K/A | View |
2025-09-18 | 4 | View |
2025-09-16 | 4 | View |
2025-09-15 | PRE 14A | View |
2025-09-12 | 4 | View |
2025-09-12 | 4 | View |
2025-09-12 | 3 | View |
2025-09-12 | SCHEDULE 13D | View |
2025-09-12 | 144 | View |
2025-09-12 | 144 | View |
2025-09-11 | 4 | View |
2025-09-11 | 4 | View |
2025-09-09 | 144 | View |